| Authors: |
Oswald LB; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Li X; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Ferraris CE; College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL., De Avila G; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Scheiber-Camoretti D; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Gudenkauf LM; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Small BJ; School of Nursing, The University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, NC., Gonzalez BD; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Nguyen O; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Crowder SL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Parker N; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Vinci CE; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Baz RC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Shain KH; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Blue B; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Grajales-Cruz AF; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Matte K; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Kale B; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Kaldas D; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Perna F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Alsina M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Castaneda Puglianini O; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Liu H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Jim HSL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Peres LC; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL. |